Publication date: 10 September 2026 Source: Molecular Therapy Advances, Volume 34, Issue 3 Author(s): Andreia Gomes-Duarte, Jamie K. Wong, Alessandro Moro, Svetlana Pasteuning-Vuhman, Wouter Pos, Rob Haselberg, Marina Sogorb-González, Sofia Pascoal, Linda Borst, Madhurima Chatterjee, Martin Giera, Sotirios Tsimikas, Saud A. Sadiq, Sander van Deventer
Neutralization of pathogenic PC-OxPL by AAV-delivered scFv as a therapeutic strategy for amyotrophic lateral sclerosis. // Molecular Therapy Advances. – URL: https://www.sciencedirect.com/science/article/pii/S3117387X26001576?dgcid=rss_sd_all
Neutralization of pathogenic PC-OxPL by AAV-delivered scFv as a therapeutic strategy for amyotrophic lateral sclerosis. Molecular Therapy Advances. https://www.sciencedirect.com/science/article/pii/S3117387X26001576?dgcid=rss_sd_all
“Neutralization of pathogenic PC-OxPL by AAV-delivered scFv as a therapeutic strategy for amyotrophic lateral sclerosis.” Molecular Therapy Advances.
@article{article119267,
title = {Neutralization of pathogenic PC-OxPL by AAV-delivered scFv as a therapeutic strategy for amyotrophic lateral sclerosis},
journal = {Molecular Therapy Advances},
url = {https://www.sciencedirect.com/science/article/pii/S3117387X26001576?dgcid=rss_sd_all}
}